Bacil Pharma Limited

Equities

BACPHAR6

INE711D01018

Delayed Bombay S.E. 04:45:20 2024-05-29 am EDT 5-day change 1st Jan Change
24.3 INR +4.97% Intraday chart for Bacil Pharma Limited +15.44% +280.88%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Bacil Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Bacil Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Bacil Pharma Limited Appoints Mrs. Bhavana Tak as Company Secretary and Compliance Officer CI
Bacil Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Bacil Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Bacil Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Bacil Pharma Limited Announces Resignation of Vaishali Vaghasiya, Company Secretary & Compliance , Effective 1 April,2023 CI
Bacil Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Bacil Pharma Limited Appoints Suman Shah as Non-Executive Non- Independent Director CI
Bacil Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Bacil Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Bacil Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Bacil Pharma Gets Board Approval to Foray into Agricultural Business MT
Bacil Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Bacil Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Bacil Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Bacil Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Bacil Pharma Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020 CI
Bacil Pharma Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020 CI
Bacil Pharma Limited Announces Appointment of Vaishali Vaghasiya as Company Secretary and Compliance Officer CI
Bacil Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2020 CI
Bacil Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020 CI
Bacil Pharma Limited Announces Resignation of Shweta Motwani as Company Secretary and Compliance Officer CI
Bacil Pharma Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019 CI
Bacil Pharma Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019 CI
  1. Stock Market
  2. Equities
  3. BACPHAR6 Stock
  4. News Bacil Pharma Limited
  5. Bacil Pharma Narrows Net Loss in Fiscal Q4